A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment
- DOI
- 10.1016/j.conctc.2023.101116
- Published
- 2023-06
- Container
- Contemporary Clinical Trials Communications
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.conctc.2023.101116,
title = {A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment},
author = {JoAnn Difede and Andrew A. McAleavey and Mariel Emrich and Adina Jick and Annell Ovalles and Katarzyna Wyka and Lisa Spielman and Megan Olden and Melissa Peskin and Colleen Becket-Davenport and Amy Rubenstein and Michael J. Brownstein and Eve Damiano and Debra Itzkowitz and Shi-fang Lu and Nancy J. Needell and James H. Kocsis and Janna S. Gordon-Elliott and Neal G. Simon},
year = {2023},
journal = {Contemporary Clinical Trials Communications},
doi = {10.1016/j.conctc.2023.101116},
url = {https://doi.org/10.1016/j.conctc.2023.101116}
}RIS
TY - JOUR TI - A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment AU - JoAnn Difede AU - Andrew A. McAleavey AU - Mariel Emrich AU - Adina Jick AU - Annell Ovalles AU - Katarzyna Wyka AU - Lisa Spielman AU - Megan Olden AU - Melissa Peskin AU - Colleen Becket-Davenport AU - Amy Rubenstein AU - Michael J. Brownstein AU - Eve Damiano AU - Debra Itzkowitz AU - Shi-fang Lu AU - Nancy J. Needell AU - James H. Kocsis AU - Janna S. Gordon-Elliott AU - Neal G. Simon PY - 2023 JO - Contemporary Clinical Trials Communications DO - 10.1016/j.conctc.2023.101116 UR - https://doi.org/10.1016/j.conctc.2023.101116 ER -
APA
Difede, J., McAleavey, A. A., Emrich, M., Jick, A., Ovalles, A., Wyka, K., Spielman, L., Olden, M., Peskin, M., Becket-Davenport, C., Rubenstein, A., Brownstein, M. J., Damiano, E., Itzkowitz, D., Lu, S., Needell, N. J., Kocsis, J. H., Gordon-Elliott, J. S., & Simon, N. G. (2023). A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment. Contemporary Clinical Trials Communications. https://doi.org/10.1016/j.conctc.2023.101116
Source records
- crossref · retrieved 2026-09-27T01:17:47.634Z